NewsTHE ANNALS OF PHARMACOTHERAPYTuesday, December 30, 2025 · December 30, 2025
Sotatercept: A New Frontier in Pulmonary Arterial Hypertension Treatment.
WHY IT MATTERS
Recent peer-reviewed research on Pulmonary arterial hypertension that may be relevant for patients and caregivers.
To review the pharmacology, pharmacokinetics, safety, and efficacy of sotatercept for the management of pulmonary arterial hypertension (PAH). A literature search in PubMed, EMBASE, and the National Institutes of Health Clinical Trials Registry (http://www. gov) was conducted from January 2009 to Ju...
Related conditions
Related news
Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.…
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.…
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.…
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.…